Electrophysiology Mapping and Ablation Devices | Market Insights | Europe (Supplemental) | 2021
The European market for EP mapping and ablation devices will experience moderate growth through 2029, largely as a result of increasing ablation volumes and the use of premium-priced devices in AF treatments. Growth will be hindered to some extent in 2020 due to the COVID-19 pandemic, resulting in delayed procedures for EP and ablation.
This Medtech 360 Report provides key market metrics for the EP mapping and ablation device market in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.